CONFLICT OF INTEREST POLICIES AND DISCLOSURE REQUIREMENTS AMONG EUROPEAN SOCIETY OF CARDIOLOGY NATIONAL CARDIOVASCULAR JOURNALS

1. International Committee of Medical Journals Editors. Uniform Requirements for Manuscript Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. (Updated October 2008). Available: http://www.icmje.org/.

2. Council of Science Editors. CSE´s White Paper on Promoting Integrity in Scientific Journal Publications. Editorial policy committee (2005-2006). Available: http://www.CouncilScienceEditors.org.

3. World Association of Medical Editors. WAME recommendations on Publication Ethics and Policies for Medical Journals. Available: http://www.wame.org/resources/ethics-resources.

4. Committee On Publication Ethics. COPE. Code of Conduct and Best Practice Guidelines for Journal Editors. Available: http://publicationethics.org/resources/guidelines.

5. Alfonso F ., Bermejo J., Segovia J. New recommendations of the international committee of medical journal editors. Shifting focus: from uniformity in technical requirements to bioethical considerations. Rev Esp Cardiol. 2004 Jun; 57(6):592-3.

6. Blum J.A., Freeman K., Dart R.C., Cooper R.J. Requirements and definitions in conflict of interest policies of medical journals. JAMA 2009; 302(20):2230-34.

7. Cooper R.J., Gupta M., Wilkes M.S., Hoffman J.R. Conflict of Interest Disclosure Policies and Practices in Peer-re-viewed Biomedical Journals. J Gen Intern Med. 2006; 21(12):1248-1252.

8. Bekelman J.E., MPhil Y .L., Gross C.P . Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289(4):454-465.

9. DeAngelis C.D., Fontanarosa P .B. Resolving unreported conflicts of interest. JAMA 2009; 302(2):198-199.

10. Studdert D.M., Mello M.M., Phil M., Brennan TA. Financial conflicts of interest in physicians´ relationships with the pharmaceutical industry . Self-regulation in the shadow of federal prosecution. N Engl J Med 2004; 351:1891-1900.

11. Drazen J.M., Van der Weyden M.B., Sahni P ., Rosenberg J., Marusic A., Laine C., Kotzin S., Horton R., Hébert P .C., Haug C., Godlee F ., Frizelle F .A., de Leeuw P .W., DeAngelis C.D. Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med. 2009; 361(19):1896-7.

12. Drazen J.M., de Leeuw P .W., Laine C., Mulrow C., DeAngelis C.D., Frizelle F .A., Godlee F ., Haug C., Hébert P .C., James A., Kotzin S., Marusic A., Reyes H., Rosenberg J., Sahni P ., Van der Weyden M.B., Zhaori G. Toward more uniform conflict disclosures — The updated ICMJE conflict of interest reporting form. N Engl J Med. 2010; 363(2):188-9.

13. Alfonso F ., Ambrosio G., Pinto F .J., Van der Wall E.E., Kondili A., Nibouche D., Adamyan K., Huber K., Ector H., Masic I., Tarnovska R., Ivanusa M., Stanĕk V., Videbaek J., Hamed M., Laucevicius A., Mustonen P ., Artigou J.Y ., Cohen A., Rogava M., Böhm M., Fleck E., Heusch G., Klawki R., Vardas P ., Stefanadis C., Tenczer J., Chiariello M., Elias J., Benjelloun H., Rødevand O., Kułakowski P ., Apetrei E., Lusov V.A., Oganov R.G., Obradovic V., Kamensky G., Kenda M.F ., Höglund C., Lüscher T.F ., Lerch R., Jokhadar M., Haouala H., Sansoy V., Shumakov V., Timmis A. European National Society cardiovascular journals. Background, rationale and mission statement of the "Editors' Club". Rev Esp Cardiol. 2008 Jun; 61(6):644-50.

14. Alfonso F ., Ambrosio G., Pinto F .J., Ector H., Vardas P ., Kulakowski P ., Timmis A.; Editors' Network ESC Task Force. European Society of Cardiology national cardiovascular journals: the 'Editors' Network'. Eur Heart J. 2010 Jan; 31(1):26-8.

15. Mills P ., Timmis A., Huber K., Ector H., Lancellotti P ., Masic I., Ivanusa M., Antoniades L., Aschermann M., Laucevicius A., Mustonen P ., Artigou J.Y ., Vardas P ., Stefanadis C., Chiarello M., Bolognese L., Ambrosio G., van der Wall E.E., Kułakowski P ., Pinto F .J., Apetrei E., Oganov R.G., Kamensky G., Lüscher T.F ., Lerch R., Haouala H., Sansoy V., Shumakov V., Tajer C.D., Lau C.P ., Márquez M., Krittayaphong R., Arai K., Alfonso F . The role of European national journals in education. Heart. 2009 Dec; 95(24):e3.

16. Alfonso F . The Editors' Network of the European Society of Cardiology. Eur Heart J. 2011 Apr; 32(8):919-21.

17. Schwartz R.S., Curfman G.D., Morrissey S., Drazen J.M. Full disclosure and the funding of biomedical research. N Engl J Med 2008; 358(17):1850-1.

18. Simone J. More interest in conflicts of interest. Lancet Oncol. 2009; 10:836-7.

19. Conti R.C. Conflict of interest. Clin Cardiol 2009; 32:666-667

20. Fontanarosa P .B., Flanagin A., DeAngelis C.D. Reporting conflicts of interest, financial aspects of research and role of sponsors in funded studies. JAMA 2005; 294(1):110-11.

21. Alpert J.S. Doctors and the drug industry: how can we handle potential conflicts of interest? Am J Med. 2005 Feb; 118(2):99-100.

22. Alpert J.S. Doctors and the drug-industry: Further thoughts for dealing with potential conflicts of interest? Am J Med 2008 Apr; 121(4):253-5.

23. Lanier W.L. Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? Mayo Clin Proc. 2009 Sep; 84(9):771-5.

24. Bove A. Relations with industry: thoughts on claims of a broken system. J Am Coll Cardiol 2009; 54(2):177-79.

25. Bodenheimer T . The uneasy alliance: Clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 342(20):1539-44.

26. Goldacre B. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes. BMJ. 2009 Nov 27; 339:b4949.

27. Davidoff F ., de Angelis C.D., Drazen J.M., Hoey J., Hjgaard L., Horton R., Kotzin S., Nicholls M.G., Nylenna M., Overbeke J.P ., Sox H.C., van der Weyden M.B., Wilkes M.S.; International Committee of Medical Journal Editorset al. Sponsorship, authorship and accountability. Lancet. 2001; 358:854-6.

28. Johns M.M., Barners M., Florencio P .S. Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust. JAMA. 2003; 289(6):741-6.

29. Alfonso F ., Segovia J., Heras M., Bermejo J. Publication of clinical trials in scientific journals: Editorial issues. Rev Esp Cardiol. 2006 Nov; 59(11):1206-14.

30. Patsopoulos N.A., Analatos A.A., Ioannidis J.P . Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ. 2006; 332(7549):1061-4.

31. Lexchin J., Bero L.A., Djulbegovic B., Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003; 326(7400):1167-70.

32. Finucane T .E., Boult C.E. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Am J Med. 2004; 117(11):842-5.

33. Hirsch L.J. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: The tort bar and editorial oversight of medical journals. Mayo Clin Proc 2009; 84(9):811-821.

34. Krzyanowska M.K., Pintilie M., Tannock I.F . Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA. 2003; 290(4):495-501.

35. Chan A.W., Krleza-Jerić K., Schmid I., Altman D.C. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ. 2004; 171(7):735-740.

36. Alfonso F ., Bermejo J., Segovia J. Duplicate or redundant publication: can we afford it?. Rev Esp Cardiol. 2005 May; 58(5):601-4.

37. Hirsch L. Randomized clinical trials: what gets published, and when? CMAJ. 2004; 170(4):481-483.

38. Kjaergard L.L., Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ. 2002; 325(7358):249

39. Ridker P .M., Torres J. Reported outcomes in major cardiovascular clinical trials funded by for profit and not-for-profit organizations: 2000-2005. JAMA. 2006; 295(19):2270-4.

40. Krimsky S., Rothenberg L.S. Conflict of interest policies in science and medical journals: editors practices and authors disclosures. Sci Eng Ethics 2001; 7(2):205-218.

41. Ancker J.S., Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics 2007; 13(2):147-57.

42. Weinfurt K.P ., Seils D.M., Tzeng J.P ., Lin L., Schulman K.A., Califf R.M. Consistency of financial interest disclosures in the biomedical literature: The case of coronary stents. PLoS ONE 2008; 3(5):e2128.

43. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2005; 2(5):e138.

44. The Editors. Publishing commentary by authors with potential conflicts of interest: When, Why and How. Annals Intern Med 2004; 141(1):73-74.

45. Vorobiof G. Do conflict of interest really matter or does no one read the fine print anyway? J Am Coll Cardiol 2008; 51(19):1911.

46. T anne J.H. US Senate committee investigates conflicts of interest in industry funded medical education. BMJ. 2009 Aug 4; 339:b3139.

47. Rothman K.J. Conflict of interest. The new McCarthyism in science. JAMA 1993; 269(21):2782-2784.

48. Avanzas P ., Bayes-Genis A., Pérez de Isla L., Sanchis J., Heras M. Ethical considerations in the publication of scientific articles. Rev Esp Cardiol. 2011 May; 64(5):427-9.

49. Relations between professional medical associations and the health-care industry , concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology. EurHeart J. 2012;33:666-74.